The commissioning of tocilizumab subcutaneous injection is accepted in Devon as an alternative treatment option to tocilizumab intravenous infusion for the treatment of rheumatoid arthritis where use is in line with NICE guidance for tocilizumab (NICE TA247 and NICE TA375)
| Filename: | Tocilizumab subcutaneous injection for rheumatoid arthritis |
| Filetype: | |
| Filesize: | 95.73 KB |
| Date uploaded: | 22nd March 2016 |
| Date updated: | 8th December 2022 |
